Adage Capital Partners Gp, L.L.C. Reata Pharmaceuticals Inc Transaction History

Adage Capital Partners Gp, L.L.C.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$79.22 - $105.37 $103 Million - $137 Million	1,296,452 Added 276.07%	1,766,070 $180 Million
Q1 2023 May 15, 2023	SELL	$30.85 - $93.17 $25.8 Million - $77.9 Million	-836,235 Reduced 64.04%	469,618 $42.7 Million
Q4 2022 Feb 14, 2023	BUY	$22.15 - $42.11 $23.6 Million - $44.9 Million	1,065,829 Added 444.05%	1,305,853 $49.6 Million
Q3 2022 Nov 14, 2022	SELL	$19.41 - $36.49 $15.2 Million - $28.6 Million	-784,976 Reduced 76.58%	240,024 $6.03 Million
Q2 2022 Aug 15, 2022	BUY	$20.71 - $36.5 $21.2 Million - $37.4 Million	1,025,000 New	1,025,000 $31.2 Million
Q4 2021 Feb 14, 2022	SELL	$25.61 - $110.96 $435,370 - $1.89 Million	-17,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$100.0 - $143.02 $1.7 Million - $2.43 Million	17,000 New	17,000 $1.71 Million
Q2 2020 Aug 14, 2020	SELL	$126.3 - $176.56 $10.1 Million - $14.1 Million	-80,000 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$124.16 - $247.74 $4.1 Million - $8.18 Million	-33,000 Reduced 29.2%	80,000 $11.5 Million
Q4 2019 Feb 14, 2020	BUY	$74.57 - $217.92 $1.34 Million - $3.92 Million	18,000 Added 18.95%	113,000 $23.1 Million
Q3 2019 Nov 14, 2019	BUY	$71.26 - $95.75 $3.56 Million - $4.79 Million	50,000 Added 111.11%	95,000 $7.63 Million
Q2 2019 Aug 14, 2019	BUY	$77.72 - $94.35 $3.5 Million - $4.25 Million	45,000 New	45,000 $4.25 Million

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.